Humana stock a bet on healthcare for seniors, Barron’s says

Even health insurers can catch a cold-and that has created a buying opportunity in Humana(HUM) stock, Jacob Sonenshine writes in this week’s edition of Barron’s. Humana, unlike some other insurers, focuses on older Americans. Medicare Advantage is where Humana really excels. The plans offer seniors a bundled set of benefits that provide Medicare Parts A, B, and D benefits and charge few out-of-pocket fees. That business generated nearly $73 billion in sales in 2022, or 80% of Humana’s insurance revenue. The company is the second-largest player in the space, trailing only UnitedHealth Group (UNH). As Medicare Advantage goes, so goes Humana, the author adds. Reference Link